The Democratic Republic of the Congo is once again at the epicenter of a deadly Ebola outbreak, but this time, it’s a lesser-known culprit: the Bundibugyo virus. Since mid-May 2026, the World Health Organization (WHO) has tracked about 1,000 confirmed cases and hundreds of deaths in the remote, volatile provinces of Ituri, Nord-Kivu, and Sud-Kivu. The Bundibugyo virus—a rare Ebola species discovered in Uganda less than two decades ago—has only caused two previous outbreaks before this one, all in the Congo River basin.
International Response and Aid Efforts
Health workers on the ground are up against staggering odds. Not only are they grappling with a shortage of medical supplies, but there’s also the ever-present threat of armed groups and a deeply distrustful population. The European Union just delivered much-needed medical aid to Ituri province, while the United States announced an additional $80 million in assistance, bringing its total commitment to more than $112 million. Yet, these efforts are only part of the battle. WHO Director-General Tedros Adhanom Ghebreyesus arrived in Kinshasa this week, calling for a ceasefire amid ongoing violence, emphasizing, “We cannot build community trust or isolate the sick while bombs are falling.”
No Vaccine, No Cure: The Challenge of Bundibugyo
Unlike other Ebola strains, Bundibugyo has no approved vaccines or treatments, complicating the outbreak response. The WHO advisory group has pinpointed several potential vaccines and therapies, but they’re only available in clinical trials and would require months to develop and test for safety and effectiveness. “This is just the third time Bundibugyo has been the cause of an identified outbreak,” said Dr. Tom Ksiazek of the University of Texas Medical Branch. The rarity of the virus means there’s limited experience and even less infrastructure for a coordinated medical response.
The outbreak’s ferocity is especially alarming given the region’s history of conflict, food insecurity, and mass displacement. In a controversial move, the U.S. decided to send exposed American workers to a quarantine facility in Kenya—a country with no Ebola cases—prompting a Kenyan court to temporarily halt the plan after public outcry.
An American health worker exposed in DRC was recently transported to Germany for treatment and is reportedly in stable condition. Meanwhile, the CDC is monitoring for possible spread to Uganda, with public health advisories in place for travelers returning from affected regions.
As global health agencies race to contain the epidemic, the Bundibugyo outbreak is a stark reminder: in the fight against Ebola, the world is still playing catch-up—especially when confronted by a virus with no playbook.
